期刊文献+
共找到3篇文章
< 1 >
每页显示 20 50 100
溴隐亭在基础催乳素正常患者中的治疗作用 被引量:4
1
作者 董若琳 黄引平 吴丽群 《实用妇产科杂志》 CAS CSCD 北大核心 2008年第9期557-559,共3页
目的:了解基础血清催乳素(PRL)正常的排卵障碍患者中潜在性高催乳素血症(OHP)和临界潜在性高催乳素血症的发生率,观察溴隐亭(CB154)促排卵治疗的临床疗效。方法:对125例基础血清PRL正常无排卵患者,行黄体生成激素释放激素(LHRH)负荷试验... 目的:了解基础血清催乳素(PRL)正常的排卵障碍患者中潜在性高催乳素血症(OHP)和临界潜在性高催乳素血症的发生率,观察溴隐亭(CB154)促排卵治疗的临床疗效。方法:对125例基础血清PRL正常无排卵患者,行黄体生成激素释放激素(LHRH)负荷试验,筛选出潜在性高催乳素血症患者(OHP组,34例)和临界潜在性高催乳素血症患者(临界OHP组,47例),2组患者均予溴隐亭治疗,并监测排卵情况。结果:125例患者中OHP发生率27.2%,临界OHP发生率37.6%。OHP组和临界OHP组经溴隐亭治疗显效率分别为35.3%、10.6%;有效率分别为61.8%、89.4%;无效率分别为2.9%、0。OHP组显效率高于临界OHP组(P<0.05),临界OHP组有效率高于OHP组(P<0.05),两组无效率比较,差异无统计学意义(P>0.05)。结论:在排卵障碍妇女中,LHRH负荷试验可筛选出OHP患者和临界OHP患者,溴隐亭能提高排卵率,可用于治疗OHP和临界OHP的患者,治疗OHP的效果比临界OHP好。 展开更多
关键词 排卵障碍 潜在性高催乳素血症 溴隐亭 黄体生成激素释放激素负荷试验
下载PDF
联合运用重组人生长激素和雌激素对去势大鼠骨密度及生物力学的影响 被引量:8
2
作者 胡亚军 郭三萍 +2 位作者 李晓红 唐成芳 肖卓 《中国骨质疏松杂志》 CAS CSCD 2007年第2期91-95,共5页
目的研究重组人生长激素和雌激素联合用药对去势大鼠股骨、下颌骨骨密度及生物力学的影响。方法选4月龄SD雌性大鼠,随机分为5组:假手术组(sham-OVX)、骨质疏松组(OVX)、雌激素组(E2)、重组人生长激素组(rh-GH)、联合用药组(E2+rh-GH),... 目的研究重组人生长激素和雌激素联合用药对去势大鼠股骨、下颌骨骨密度及生物力学的影响。方法选4月龄SD雌性大鼠,随机分为5组:假手术组(sham-OVX)、骨质疏松组(OVX)、雌激素组(E2)、重组人生长激素组(rh-GH)、联合用药组(E2+rh-GH),于去势后8w,各组分别腹腔给予相应的药物,4w末及8w末分两批处死各组大鼠,取股骨和下颌骨新鲜标本,进行骨密度(BMD)与最大载荷的实验研究。结果用药4w末及8w末,OVX组下颌骨和股骨BMD均显著低于其他4组。E2+rh-GH组下颌骨BMD较E2组和rh-GH组高,但是差异均无统计学意义(P>0.05)。用药4w末及8w末,OVX组下颌骨和股骨最大载荷均显著低于sham-OVX组和用药组。E2+rh-GH组下颌骨及股骨最大载荷比E2组、rh-GH组高,用药4w末联合用药组与单一用药组最大载荷的差异有统计学意义;而用药后8w末差异均无统计学意义。结论雌激素、重组人生长激素及两者联合用药都能有效的抑制骨质疏松大鼠颌骨及股骨骨量的丢失,提高骨强度。联合用药与单一用药对下颌骨骨密度的影响没有明显的差异,可能与测量的方法和测量部位结构有关。联合用药对股骨骨密度、最大载荷及颌骨最大载荷的作用与用药时间有关,短期内效果优于单独用药。 展开更多
关键词 重组人生长激素 雌激素 绝经后骨质疏松 最大载荷 骨密度 三点弯曲 双能X线骨密度测定
下载PDF
中药治疗隐匿型高催乳素血症伴早期复发性流产的临床研究 被引量:6
3
作者 田冬珍 疗鸿飞 +2 位作者 黄卉 但阳 高碧兰 《中华全科医师杂志》 2006年第5期287-290,共4页
Objective To investigate the effect of Zishengyutaiwan (ZSYTW), a kind of traditional Chinese herbal medicine, in treating occult hyperprolactinemia (OHP) with early recurrent abortion. Methods Fifty-six cases of ... Objective To investigate the effect of Zishengyutaiwan (ZSYTW), a kind of traditional Chinese herbal medicine, in treating occult hyperprolactinemia (OHP) with early recurrent abortion. Methods Fifty-six cases of OHP were detected from 151 cases with cause-unknown recurrent abortion by thyroid-releasing hormone (TRH) load test, who were randomly divided into two groups, one group (31 cases) was treated with ZSYTW and the other (25 cases) with bromocriptine as controls. Serum levels of estradiol (E2) and progesterone (P) were measured and vaginal ultrasound scanning was performed on the 21st to 25th days of menstruation to measure their endometrial thickness for all the subjects before and after treatment. And, serum levels of P, prolactine (PL) and chorionic gonodotrophin (CGT) were measured within eight weeks of conception. Results There was no significant difference in serum level of E2 before and after treatment in both groups. But, serum level of P and endometrial thickness showed significant difference before and after treatment between two groups (P<0.05 and P<0.01, respectively). Serum level of P indicated insufficient luteal function in one (3.4%) of 29 cases with ZSYTW after conception, with 27 successful pregnancy (87.1%) and two abortions, and insufficient luteal function in four cases (20.0%) of 20 cases with western medicine after conception, with 19 successful pregnancy (76.0%) and one abortion (P<0.05 and P>0.05, respectively). Conclusions SOHP closely related to recurrent abortion. OHP in cause-unknown recurrent abortion could be detected by TRH load test. Traditional Chinese herbal medicine ZSYTW could improve luteal function and intro-environment of endometrium more than bromocriptine could. 展开更多
关键词 高催乳素血症 促甲状腺释放激素负荷试验 流产 习惯性 中药治疗
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部